Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Deepak L. Bhatt, MD, MPH: Let me turn now to Dr Navar to discuss what I think is an important part of the discussion. She’s done a lot of work on this. How do we actually estimate patients’ risk for ...

Read this article to learn how to conduct an advanced cardiovascular assessment to reveal heart abnormalities and associated symptoms and risk factors. Cardiovascular disease remains one of the ...

Please provide your email address to receive an email when new articles are posted on . Peripheral artery disease, or PAD, is a leading cause of lower extremity amputations in the U.S. Health care use ...

Before tissue-engineered blood vessels reach the clinic, they must withstand the mechanical stresses of the vascular system—an assessment that is essential, but often expensive. One University of ...

Computed tomographic (CT) imaging can be used as a screening tool to assess the iliofemoral artery and predict the risk of vascular complications in candidates for transcatheter aortic valve ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk-screening and stratification is advised for IBD patients before JAK inhibitor or S1P ...

Vascular Access Device Market OverviewThe global vascular access device market is witnessing consistent growth and is ...

The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV ...